- Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platformNovartis said Monday it will be spending $1.1 billion upfront to buy Myricx Bio, which has an antibody-drug conjugate payload platform that could offer an edge over current approaches. The Swiss…Endpoints · 20d ago↗ source
- Anthropic launches Claude Science; House China panel probes trial sites; and moreHappy Fourth of July! We’ve got a handful of stories worth checking out before the backyard barbecue begins. But first: a reminder to submit your nominations for this year’s Women in Biopharma ...Endpoints · 22d ago↗ source
- When clinical AI gets realWe’re heading toward a future in which certain parts of medical care are delivered without any humans involved. Cadence, which raised a $100 million Series C last week, is betting that it can mak…